explore -WSS

explore

author：hotspot 2025-10-01 00:58:30 - browse：25

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

WSS

Mega Millions pot grows to $1.25 billion after no winner

Trump indictment: Who are the 'co

Acelyrin, a rare IPO success, stumbles in its first big test

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Amazon expands telehealth clinic nationwide

focus

explore

explore

The high cost of giving birth even with insurance

How housing is health care on Long Island

Tori Bowie and the unacceptable rates of Black maternal death

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Dobbs anniversary: the lost opportunity of abortion as health care

Vertex non

At least 13 dead in Texas as scorching temps continue

NIH launches clinical trials and new research office for long Covid

DIEP, the 'gold standard' of breast reconstruction, is under threat

National panel will explore requiring free Covid tests

Wikipedia

EQRx, failed developer of low

EQRx, failed developer of low

How medical schools plan to diversify without affirmative action

What the US credit downgrade means for the economy, your finances

Diverse clinical trials: Why aren’t we there yet?

5 important ways Henrietta Lacks changed medical science

leisure time

entertainment

hotspot

explore